multicentric castleman's disease - Sports Zone
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman’s disease (iMCD). This rare ... BioWorld: Beigene’s siltuximab gets China nod for multicentric Castleman disease as firm preps $3.5B STAR Market listing Beigene Ltd.
Understanding the Context
has received approval from China’s NMPA to market Sylvant (siltuximab) for the treatment of patients with multicentric Castleman disease, including HIV-negative and human herpes ... Beigene’s siltuximab gets China nod for multicentric Castleman disease as firm preps $3.5B STAR Market listing ascopubs.org: Prospective Study of Rituximab in Chemotherapy-Dependent Human Immunodeficiency Virus–Associated Multicentric Castleman's Disease: ANRS 117 CastlemaB Trial Prospective Study of Rituximab in Chemotherapy-Dependent Human Immunodeficiency Virus–Associated Multicentric Castleman's Disease: ANRS 117 CastlemaB Trial The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat multicentric Castleman’s disease. MCD is a rare disorder that causes an abnormal overgrowth of immune cells in lymph ...
Image Gallery
Key Insights
Morningstar: Recordati Rare Diseases Showcases Real-World Evidence Studies That Advance Understanding of Castleman Disease (CD) at the American Society of Hematology (ASH) Annual Meeting Recordati Rare Diseases Showcases Real-World Evidence Studies That Advance Understanding of Castleman Disease (CD) at the American Society of Hematology (ASH) Annual Meeting Castleman's disease represents a spectrum of rare lymphoproliferative disorders that share common histopathological features yet exhibit diverse clinical presentations. Traditionally divided into ...